An agent-based model of solid tumor progression

Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics)

Volumn 5462 LNBI, Issue , 2009, Pages 187-198

  Dréau, Didier ^a   Stanimirov, Dimitre ^b   Carmichael, Ted ^b   Hadzikadic, Mirsad ^b  

^a UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

^b University of North Carolina at Charlotte   (United States)

Author keywords

Agents; Cell simulation; Self migration; Self organization; Self regulation

Indexed keywords

ACTIVE OBJECT; AGENT-BASED MODEL; AGENT-BASED SYSTEMS; BIOLOGICAL MODELS; CANCER CELLS; CELL SIMULATION; COMPLEX SYSTEMS; COMPUTER SIMULATION MODEL; ENERGY AVAILABILITY; HOST IMMUNE RESPONSE; IMMUNE CELLS; IMMUNE SYSTEMS; MULTI-AGENT MODELING; NETLOGO; RESEARCH TOOLS; SELF-MIGRATION; SELF-ORGANIZATION; SELF-REGULATION; SIMULATION TECHNIQUE; SOLID TUMORS; TUMOR CELLS; TUMOR PROGRESSIONS; TUMOR VASCULARIZATION;

BIOINFORMATICS; CELL MEMBRANES; COMPUTER SIMULATION LANGUAGES; IMMUNOLOGY; MULTI AGENT SYSTEMS; ONCOLOGY; TUMORS;

SIMULATORS;

EID: 68249087592     PISSN: 03029743     EISSN: 16113349     Source Type: Book Series    
DOI: 10.1007/978-3-642-00727-9_19     Document Type: Conference Paper

References (24)

1. Komarova, N.L.: Mathematical modeling of tumorigenesis: mission possible. Curr. Opin. Oncol. 17, 39-43 (2005)
2. Grizzi, F., Russo, C., Colombo, P., Franceschini, B., Frezza, E.E., Cobos, E., Chiriva- Internati, M.: Quantitative evaluation and modeling of two-dimensional neovascular network complexity: the surface fractal dimension. BMC Cancer 5, 1-14 (2005)
3. Kohandel, M., Kardar, M., Milosevic, M., Sivaloganathan, S.: Dynamics of tumor growth and combination of anti-angiogenic and cytotoxic therapies. Phys. Med. Biol. 52, 3665-3677 (2007)
4. Geromichalos, G.D.: Importance of molecular computer modeling in anticancer drug development. J. B. U. On. 12(suppl. 1), S101-S118 (2007)
5. Chaplain, M.A., McDougall, S.R., Anderson, A.R.: Mathematical modeling of tumorinduced angiogenesis. Annu. Rev. Biomed. Eng. 8, 233-257 (2006)
6. Gevertz, J.L., Torquato, S.: Modeling the effects of vasculature evolution on early brain tumor growth. J. Theor. Biol. 243, 517-531 (2006)
7. Iafolla, M.A., McMillen, D.R.: Extracting biochemical parameters for cellular modeling: A mean-field approach. J. Phys. Chem. B 110, 22019-22028 (2006)
8. Delsanto, P.P., Condat, C.A., Pugno, N., Gliozzi, A.S., Griffa, M.: A multilevel approach to cancer growth modeling. J. Theor. Biol. 250, 16-24 (2008)
9. Zhang, L., Athale, C.A., Deisboeck, T.S.: Development of a three-dimensional multiscale agent-based tumor model: simulating gene-protein interaction profiles, cell phenotypes and multicellular patterns in brain cancer. J. Theor. Biol. 244, 96-107 (2007)
10. Mantovani, A., Marchesi, F., Porta, C., Sica, A., Allavena, P.: Inflammation and cancer: breast cancer as a prototype. Breast 16(suppl. 2), S27-S33 (2007)
11. de Pillis, L.G., Gu, W., Radunskaya, A.E.: Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations. J. Theor. Biol. 238, 841-862 (2006)
12. Mallet, D.G., de Pillis, L.G.: A cellular automata model of tumor-immune system interactions. J. Theor. Biol. 239, 334-350 (2006)
13. Knowles, J., Loizidou, M., Taylor, I.: Endothelin-1 and angiogenesis in cancer. Curr. Vasc. Pharmacol. 3, 309-314 (2005)
14. Wilensky, U.: NetLogo, Center for Connected Learning and Computer-Based Modeling. Northwestern University, Evanston, IL (1999), http://ccl.northwestern. edu/netlogo
15. de Pillis, L.G., Mallet, D.G., Radunskaya, A.E.: Spatial tumor-immune modeling. Computational and Mathematical Methods in medicine 7, 159-176 (2006)
16. Chen, K.C., Kim, J., Li, X., Lee, B.: Modeling recombinant immunotoxin efficacies in solid tumors. Ann. Biomed. Eng. 36, 486-512 (2008)
17. McGuire, B.J., Secomb, T.W.: A theoretical model for oxygen transport in skeletal muscle under conditions of high oxygen demand. J. Appl. Physiol. 91, 2255-2265 (2001)
18. Petrulio, C.A., Kim-Schulze, S., Kaufman, H.L.: The tumour microenvironment and implications for cancer immunotherapy. Expert Opin. Biol. Ther. 6, 671-684 (2006)
19. DeNardo, D.G., Johansson, M., Coussens, L.M.: Immune cells as mediators of solid tumor metastasis. Cancer Metastasis Rev. 27, 11-18 (2008)
20. Hanahan, D., Weinberg, R.A.: The hallmarks of cancer. Cell 100, 57-70 (2000)
21. Neeson, P., Paterson, Y.: Effects of the tumor microenvironment on the efficacy of tumor immunotherapy. Immunol. Invest. 35, 359-394 (2006)
22. Grande, C., Firvida, J.L., Navas, V., Casal, J.: Interleukin-2 for the treatment of solid tumors other than melanoma and renal cell carcinoma. Anticancer Drugs 17, 1-12 (2006)
23. Mukherjee, P., Ginardi, A.R., Madsen, C.S., Sterner, C.J., Adriance, M.C., Tevethia, M.J., Gendler, S.J.: Mice with spontaneous pancreatic cancer naturally develop MUC-1-specific CTLs that eradicate tumors when adoptively transferred. J. Immunol. 165, 3451-3460 (2000)
24. Dewan, M.Z., Terunuma, H., Takada, M., Tanaka, Y., Abe, H., Sata, T., Toi, M., Yamamoto, N.: Role of natural killer cells in hormone-independent rapid tumor formation and spontaneous metastasis of breast cancer cells in vivo. Breast Cancer Res. Treat. 104, 267-275 (2007)